Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 3
1963 1
1973 1
1975 1
1977 1
1978 1
1980 2
1982 1
1986 1
1987 1
1989 1
1990 2
1991 2
1992 2
1996 1
1999 1
2002 1
2003 1
2004 2
2006 2
2007 2
2008 1
2010 2
2011 3
2012 3
2013 1
2014 1
2015 3
2016 2
2017 1
2018 1
2019 2
2020 1
2021 2
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Zhang Q, Riley-Gillis B, Han L, Jia Y, Lodi A, Zhang H, Ganesan S, Pan R, Konoplev SN, Sweeney SR, Ryan JA, Jitkova Y, Dunner K Jr, Grosskurth SE, Vijay P, Ghosh S, Lu C, Ma W, Kurtz S, Ruvolo VR, Ma H, Weng CC, Ramage CL, Baran N, Shi C, Cai T, Davis RE, Battula VL, Mi Y, Wang J, DiNardo CD, Andreeff M, Tyner JW, Schimmer A, Letai A, Padua RA, Bueso-Ramos CE, Tiziani S, Leverson J, Popovic R, Konopleva M. Zhang Q, et al. Among authors: ramage cl. Signal Transduct Target Ther. 2022 Feb 21;7(1):51. doi: 10.1038/s41392-021-00870-3. Signal Transduct Target Ther. 2022. PMID: 35185150 Free PMC article.
Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells.
Jia Y, Han L, Ramage CL, Wang Z, Weng CC, Yang L, Colla S, Ma H, Zhang W, Andreeff M, Daver N, Jain N, Pemmaraju N, Bhalla K, Mustjoki S, Zhang P, Zheng G, Zhou D, Zhang Q, Konopleva M. Jia Y, et al. Among authors: ramage cl. Haematologica. 2023 Oct 1;108(10):2626-2638. doi: 10.3324/haematol.2022.281915. Haematologica. 2023. PMID: 37078252 Free PMC article.
Removing politics from innovations that improve food security.
Smyth SJ, McHughen A, Entine J, Kershen D, Ramage C, Parrott W. Smyth SJ, et al. Among authors: ramage c. Transgenic Res. 2021 Oct;30(5):601-612. doi: 10.1007/s11248-021-00261-y. Epub 2021 May 30. Transgenic Res. 2021. PMID: 34053007 Free PMC article. Review.
Minimum standards for continence care in the UK.
Rantell A, Dolan L, Bonner L, Knight S, Ramage C, Toozs-Hobson P. Rantell A, et al. Among authors: ramage c. Neurourol Urodyn. 2016 Mar;35(3):400-6. doi: 10.1002/nau.22717. Epub 2015 Jan 16. Neurourol Urodyn. 2016. PMID: 25597395 Review.
Transcriptional and phenotypic heterogeneity underpinning venetoclax resistance in AML.
Mohanty V, Baran N, Huang Y, Ramage CL, Cooper LM, He S, Iqbal R, Daher M; CTD2 Research Network; Tyner JW, Mills GB, Konopleva M, Chen K. Mohanty V, et al. Among authors: ramage cl. bioRxiv [Preprint]. 2024 Jan 30:2024.01.27.577579. doi: 10.1101/2024.01.27.577579. bioRxiv. 2024. PMID: 38352538 Free PMC article. Preprint.
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis.
Hurrish KH, Su Y, Patel S, Ramage CL, Carter JL, Edwards H, Buck SA, Wiley SE, Hüttemann M, Polin L, Kushner J, Dzinic SH, White K, Bao X, Li J, Yang J, Boerner J, Hou Z, Al-Atrash G, Konoplev SN, Busquets J, Tiziani S, Matherly LH, Taub JW, Konopleva M, Ge Y, Baran N. Hurrish KH, et al. Among authors: ramage cl. Res Sq [Preprint]. 2023 Apr 28:rs.3.rs-2843025. doi: 10.21203/rs.3.rs-2843025/v1. Res Sq. 2023. PMID: 37162954 Free PMC article. Updated. Preprint.
Regulatory approaches for genome edited agricultural plants in select countries and jurisdictions around the world.
Entine J, Felipe MSS, Groenewald JH, Kershen DL, Lema M, McHughen A, Nepomuceno AL, Ohsawa R, Ordonio RL, Parrott WA, Quemada H, Ramage C, Slamet-Loedin I, Smyth SJ, Wray-Cahen D. Entine J, et al. Among authors: ramage c. Transgenic Res. 2021 Aug;30(4):551-584. doi: 10.1007/s11248-021-00257-8. Epub 2021 May 10. Transgenic Res. 2021. PMID: 33970411 Free PMC article. Review.
[A trilogy to understand: adrenalin, allergy and anaphylaxis].
Gil-Jardine C, Lefort H, Gil C, Ramage C, Bounaud N, Chauvin A. Gil-Jardine C, et al. Among authors: ramage c. Rev Infirm. 2022 Jun-Jul;71(282):24-26. doi: 10.1016/j.revinf.2022.05.009. Epub 2022 May 26. Rev Infirm. 2022. PMID: 36150834 French.
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro.
Hurrish KH, Su Y, Patel S, Ramage CL, Zhao J, Temby BR, Carter JL, Edwards H, Buck SA, Wiley SE, Hüttemann M, Polin L, Kushner J, Dzinic SH, White K, Bao X, Li J, Yang J, Boerner J, Hou Z, Al-Atrash G, Konoplev SN, Busquets J, Tiziani S, Matherly LH, Taub JW, Konopleva M, Ge Y, Baran N. Hurrish KH, et al. Among authors: ramage cl. Biochem Pharmacol. 2024 Feb;220:115981. doi: 10.1016/j.bcp.2023.115981. Epub 2023 Dec 10. Biochem Pharmacol. 2024. PMID: 38081370
56 results